Moderna Biopharma Canada Corporation

---

Registration: 18 of 18 (2025-02-18 to present)

Details Regarding the Identified Subject Matter

Subject matters	Details	Categories
Research and Development, Science and Technology	Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology	Policies or Program
Government Procurement, Health	Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models	Policies or Program
Economic Development, Health	The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada	Policies or Program